Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia
Clinical trial NCT01614912 · COMPLETED
Trial details
- NCT number
- NCT01614912
- Sponsor
- Sumitomo Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2015-05-01
- Enrollment
- 284
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.